3 hours Needham & Company LLC Reiterates Buy Rating for Cogent Biosciences (NASDAQ:COGT)MarketBeat
Needham & Company LLC reissued a “buy” rating and issued a $16.00 target price on shares of Cogent Biosciences in a research report on Thursday.
XNeedham & Company LLC reissued a “buy” rating and issued a $16.00 target price on shares of Cogent Biosciences in a research report on Thursday.
X